Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tyler Van Buren is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/23/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.06K | 13.25% | $1030 → $1200 | Maintains | Buy | Get Alert |
| 06/24/2024 | TECX | Buy Now | Tectonic Therapeutic | $15.94 | — | — | Initiates | → Buy | Get Alert |
| 05/15/2024 | NAMS | Buy Now | NewAmsterdam Pharma | $19.00 | — | — | Initiates | → Buy | Get Alert |
| 04/26/2024 | GILD | Buy Now | Gilead Sciences | $71.19 | 19.39% | $90 → $85 | Maintains | Buy | Get Alert |
| 04/24/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.06K | -2.8% | $1020 → $1030 | Maintains | Buy | Get Alert |
| 03/01/2024 | BHVN | Buy Now | Biohaven | $37.83 | 45.39% | $35 → $55 | Maintains | Outperform | Get Alert |
| 12/11/2023 | CRSP | Buy Now | CRISPR Therapeutics | $56.25 | -46.67% | → $30 | Downgrade | Market Perform → Underperform | Get Alert |
| 12/06/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.06K | -5.63% | $900 → $1000 | Maintains | Outperform | Get Alert |
| 12/05/2023 | CRGX | Buy Now | Cargo Therapeutics | $17.48 | — | — | Initiates | → Outperform | Get Alert |
| 11/29/2023 | SYRE | Buy Now | Spyre Therapeutics | $31.67 | — | — | Initiates | → Outperform | Get Alert |
| 10/30/2023 | ACLX | Buy Now | Arcellx | $63.45 | — | — | Initiates | → Outperform | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $50.70 | — | — | Initiates | → Outperform | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $121.51 | 2.87% | $145 → $125 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/24/2023 | MRNA | Buy Now | Moderna | $121.51 | 35.79% | $175 → $165 | Maintains | Outperform | Get Alert |
| 07/06/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | → $140 | Initiates | → Outperform | Get Alert |
| 05/30/2023 | SLRN | Buy Now | Acelyrin | $6.81 | — | — | Initiates | → Outperform | Get Alert |
| 05/22/2023 | TVTX | Buy Now | Travere Therapeutics | $9.98 | 200.45% | → $30 | Initiates | → Outperform | Get Alert |
| 04/20/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.06K | -16.48% | $875 → $885 | Maintains | Outperform | Get Alert |
| 03/13/2023 | MRNA | Buy Now | Moderna | $121.51 | 48.14% | $150 → $180 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/14/2023 | KROS | Buy Now | Keros Therapeutics | $48.57 | — | — | Initiates | → Outperform | Get Alert |
| 02/06/2023 | BBIO | Buy Now | BridgeBio Pharma | $27.70 | — | — | Initiates | → Outperform | Get Alert |
| 01/30/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.06K | -17.42% | $775 → $875 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/25/2023 | MRNA | Buy Now | Moderna | $121.51 | 23.45% | $130 → $150 | Maintains | Market Perform | Get Alert |
| 01/25/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $25 → $30 | Maintains | Outperform | Get Alert |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $5.56 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/08/2022 | GILD | Buy Now | Gilead Sciences | $71.19 | 26.41% | $80 → $90 | Maintains | Outperform | Get Alert |
| 10/20/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.06K | -29.22% | $655 → $750 | Maintains | Market Perform | Get Alert |
| 08/29/2022 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | → $25 | Initiates | → Outperform | Get Alert |
| 08/08/2022 | IMCR | Buy Now | Immunocore Hldgs | $39.08 | 79.14% | → $70 | Initiates | → Outperform | Get Alert |
| 07/20/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.06K | -39.13% | $635 → $645 | Maintains | Market Perform | Get Alert |
| 07/12/2022 | ZNTL | Buy Now | Zentalis Pharma | $4.01 | — | — | Initiates | → Outperform | Get Alert |
| 06/06/2022 | TPTX | Buy Now | Turning Point | — | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/07/2021 | FATE | Buy Now | Fate Therapeutics | $5.56 | — | — | Initiates | → Outperform | Get Alert |
| 12/07/2021 | MRNA | Buy Now | Moderna | $121.51 | 105.74% | — | Initiates | → Market Perform | Get Alert |
| 12/07/2021 | CRSP | Buy Now | CRISPR Therapeutics | $56.25 | — | — | Initiates | → Market Perform | Get Alert |
| 12/07/2021 | ARVN | Buy Now | Arvinas | $28.62 | — | — | Initiates | → Outperform | Get Alert |
| 02/10/2021 | CBIO | Buy Now | Catalyst Biosciences | — | — | → $225 | Initiates | → Overweight | Get Alert |
| 08/13/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | $560 → $600 | Maintains | Overweight | Get Alert |
| 01/13/2020 | ADVM | Buy Now | Adverum Biotechnologies | $7.76 | 157.73% | $140 → $200 | Reiterates | → Overweight | Get Alert |
| 01/10/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | → $400 | Initiates | → Overweight | Get Alert |
